State Ledger
Company profile

AN2 Therapeutics, Inc. CIK 1880438

Ticker
ANTX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Menlo Park, CA 94025
Fiscal year end
2025 (FY)
Market Data
Close
$3.60
Change
-$0.71
Change %
-16.40%
Volume
17,819

ANTX · trading date Oct 13, 2026 · previous close $4.30 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$35.17M
Total assets
$61.95M
Total liabilities
$8.89M
Stockholders' equity
$53.06M
Cash & equivalents
$19.94M
Operating income
-$38.11M
Operating cash flow
-$29.83M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-17. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
14.4%
Equity / assets
85.6%
CapEx / revenue
—
Operating cash flow / net income
0.85×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$35.17M $61.95M $8.89M $53.06M
2024 — -$51.32M $92.09M $10.24M $81.85M
2023 — -$64.73M $138.74M $14.04M $124.70M
2022 — -$40.96M $102.56M $7.19M $95.37M
2021 — -$21.54M $65.32M $3.41M -$47.41M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-16
Financials filed via
Form 10-K
filed 2026-03-17

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Menlo Park, CA 94025
1300 EL CAMINO REAL, SUITE 100
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:20 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies